Disease Specific Interactions between Host Protein and DME (HOSPPI) |
Drug co-metabolism |
Cometabolized drug: Methionine |
Click to Show/Hide the Full List of HOSPPI: 8 HOSPPI
|
Methionine adenosyltransferase II beta (MAT2B) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0183
DME Info
|
Uniprot ID |
|
Interaction Name |
MAT2B-metAA interaction |
[1], [] |
Description |
The interaction, between human Methionine adenosyltransferase II beta and Homoserine-O-transsuccinylase from Salmonella enterica which collectively metabolize the drug Methionine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Methionine-R-sulfoxide reductase B1 (MSRB1) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0184
DME Info
|
Uniprot ID |
|
Interaction Name |
MSRB1-metAA interaction |
[1], [2] |
Description |
The interaction, between human Methionine-R-sulfoxide reductase B1 and Homoserine-O-transsuccinylase from Salmonella enterica which collectively metabolize the drug Methionine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Methionine-R-sulfoxide reductase B2 (MSRB2) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0185
DME Info
|
Uniprot ID |
|
Interaction Name |
MSRB2-metAA interaction |
[1], [3] |
Description |
The interaction, between human Methionine-R-sulfoxide reductase B2 and Homoserine-O-transsuccinylase from Salmonella enterica which collectively metabolize the drug Methionine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Methionine-tRNA ligase cytoplasmic (MARS) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0186
DME Info
|
Uniprot ID |
|
Interaction Name |
MARS-metAA interaction |
[1], [4] |
Description |
The interaction, between human Methionine-tRNA ligase cytoplasmic and Homoserine-O-transsuccinylase from Salmonella enterica which collectively metabolize the drug Methionine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Methionine-tRNA ligase mitochondrial (MARS2) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0187
DME Info
|
Uniprot ID |
|
Interaction Name |
MARS2-metAA interaction |
[1], [] |
Description |
The interaction, between human Methionine-tRNA ligase mitochondrial and Homoserine-O-transsuccinylase from Salmonella enterica which collectively metabolize the drug Methionine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
Peptide methionine sulfoxide reductase (MSRA) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0188
DME Info
|
Uniprot ID |
|
Interaction Name |
MSRA-metAA interaction |
[1], [5] |
Description |
The interaction, between human Peptide methionine sulfoxide reductase and Homoserine-O-transsuccinylase from Salmonella enterica which collectively metabolize the drug Methionine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
S-adenosylmethionine synthase 1 (MAT1A) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0189
DME Info
|
Uniprot ID |
|
Interaction Name |
MAT1A-metAA interaction |
[1], [6] |
Description |
The interaction, between human S-adenosylmethionine synthase 1 and Homoserine-O-transsuccinylase from Salmonella enterica which collectively metabolize the drug Methionine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
S-adenosylmethionine synthase 2 (MAT2A) |
Click to Show/Hide the Cometabolization Info |
DME ID |
DME0190
DME Info
|
Uniprot ID |
|
Interaction Name |
MAT2A-metAA interaction |
[1], [6] |
Description |
The interaction, between human S-adenosylmethionine synthase 2 and Homoserine-O-transsuccinylase from Salmonella enterica which collectively metabolize the drug Methionine, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. |
|
|
|
|
|
|